EVAX P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.25
Average-0.2310
Median-0.2400
Minimum-0.2900
Maximum-0.1800
-0.25
Past Month-0.07 (38.89%)
The P/E ratio for EVAX is -0.25 as of Jun 13, 2025. This represents a decrease of -46.81% compared to its 12-month average P/E ratio of -0.47. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Evaxion Biotech A/S P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Evaxion Biotech A/S’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Evaxion Biotech A/S to industry peers.
Evaxion Biotech A/S P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Evaxion Biotech A/S’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Evaxion Biotech A/S to industry peers.
EVAX P/E Ratio Insights
See Evaxion Biotech A/S’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in EVAX
Order type
Buy in
Order amount
Est. shares
0 shares
EVAX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $2.72 | -0.25 |
| May 1, 2025 | $1.56 | -0.17 |
| Apr 1, 2025 | $1.66 | -0.11 |
| Mar 3, 2025 | $1.89 | -0.13 |
| Feb 3, 2025 | $2.40 | -0.17 |
| Jan 2, 2025 | $4.6213 | -0.49 |
EVAX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.25 | -44.44% |
| 2024 | -0.45 | -38.36% |
| 2023 | -0.73 | -55.76% |
| 2022 | -1.65 | -53.52% |
| 2021 | -3.55 | — |
FAQs About Evaxion Biotech A/S (EVAX) P/E ratio
The latest P/E ratio of EVAX is -0.25, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Evaxion Biotech A/S’s last 12-month average P/E ratio is -0.47, compared to its current P/E ratio of -0.25. This reflects a decrease of -46.81%.
Evaxion Biotech A/S’s current P/E ratio of -0.25 is lower than its last 12-month average P/E of -0.47. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Evaxion Biotech A/S’s average P/E ratio over the last 3 years is -1.06. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Evaxion Biotech A/S’s average P/E ratio over the last 5 years is -1.98. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.